What is Synthomer selling, and why is it considered non-core?

Synthomer is selling its Czech acrylate monomers business — which produces acrylic acid and related monomers at its Sokolov site under the name Synthomer a.s. — to Mutares. The business was designated as non-core in Synthomer’s 2022 strategic review because it is 'highly cyclical and capital-intensive', representing the company’s last upstream chemicals operation; Synthomer will continue sourcing acrylic monomers and dispersions from the business post-sale.

Who is acquiring Synthomer’s Czech business, and what does this deal signify for the buyer’s strategy?

Mutares, a German-based turnaround investor headquartered in Munich, is acquiring Synthomer’s Czech acrylate monomers business. This transaction marks Mutares’ latest foray into the chemicals sector, following its January 2024 agreement to acquire SABIC’s engineering thermoplastics businesses in Europe and the Americas, and its 2026 acquisition of France-based Holliday Premium Pigments — reinforcing its growing presence alongside peer Aequita in industrial turnaround investments within chemicals.

Synthomer to Sell Czech Acrylate Monomers Business to Mutares

Jun 19, 2026

Synthomer agreed to sell its Czech acrylate monomers business to Mutares, with estimated 2025 revenues of €110 million. The deal removes a cyclical base chemicals unit from Synthomer's portfolio while maintaining supply agreements.

icis

2025-10-23

Synthomer expects 2025 earnings to reach prior-year level

2025-12-18

Synthomer Enters Receivables Purchasing Agreement with KLK

2026-01-29

Synthomer signals weaker 2025 sales, earnings amid subdued end markets

2026-06-19

Synthomer to Sell Czech Acrylate Monomers Business to Mutares

Synthomer to Sell Czech Acrylate Monomers Business to Mutares

FAQ